Sensocure is an ambitious Norwegian medical technology company, established in 2011. Our first target is to commercialise IscAlert™, the world's first implantable micro sensor for the early detection of ischemia.

Our vision is to be a market leading provider of systems and sensors for major, life-threatening disease groups, such as cancer, cardiovascular diseases, and infectious diseases.